Home › Research › Health systems and care delivery
Racial disparities in medication use: imperatives for managed care pharmacy
Stephen J Kogut. Journal of Managed Care & Specialty Pharmacy, 2020-10-29
Topic: Risk, prevention and care in population studies
The COVID-19 pandemic and the social unrest pervading U.S. cities in response to the killings of George Floyd and other Black citizens at the hands of police are historically significant. Even when cost sharing is minimal or zero, medication adherence rates have been documented to be lower among Blacks as compared with Whites.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Kogut, S. J. (2020). Racial disparities in medication use: imperatives for managed care pharmacy. Journal of Managed Care & Specialty Pharmacy. https://doi.org/10.18553/jmcp.2020.26.11.1468
Vancouver
Kogut SJ. Racial disparities in medication use: imperatives for managed care pharmacy. Journal of Managed Care & Specialty Pharmacy. 2020. doi:10.18553/jmcp.2020.26.11.1468. PMID: 33119445.
BibTeX
@article{kogut2020-33119445,
author = {Kogut, Stephen J},
title = {{Racial disparities in medication use: imperatives for managed care pharmacy}},
journal = {Journal of Managed Care \& Specialty Pharmacy},
year = {2020},
doi = {10.18553/jmcp.2020.26.11.1468},
pmid = {33119445},
url = {https://doi.org/10.18553/jmcp.2020.26.11.1468}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The COVID-19 pandemic and the social unrest pervading U.S. cities in response to the killings of George Floyd and other Black citizens at the hands of police are historically significant.
- Even when cost sharing is minimal or zero, medication adherence rates have been documented to be lower among Blacks as compared with Whites.
Why it matters
This commentary discusses racial disparities in medication use and adherence, noting that adherence rates have been documented to be lower among Black patients compared with White patients even when cost sharing is minimal or zero. It does not test any treatment, cure, or prevention of Alzheimer's disease.
Study details
- Evidence strengthLow
How this study scored 36/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of Managed Care & Specialty Pharmacy) |
| Journal's citation record | 0 / 4 | Journal of Managed Care & Specialty Pharmacy: journal h-index 60 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 34 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 4.2 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 2 / 6 | Cited 1.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 2 / 4 | Cited 22 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Stephen J Kogut: h-index 20 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | University of Rhode Island: institution h-index 474 (OpenAlex) |
| Multi-centre collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 33119445) |
| Free to read | 2 / 2 | Free to read |
| Total | 36 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.18553/jmcp.2020.26.11.1468
- PubMed: 33119445
- Original source →
- Free full text: Journal of Managed Care & Specialty Pharmacy →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Health systems and care delivery
Also in Health systems and care delivery
172 studies in the library are filed under Health systems and care delivery with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Health systems and care delivery hub.